Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1278-1282
Published online before print May 6, 2004, doi: 10.1161/01.ATV.0000131261.12051.7f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/7/1278    most recent
01.ATV.0000131261.12051.7fv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norman, P.
Right arrow Articles by Jamrozik, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norman, P.
Right arrow Articles by Jamrozik, K.
Related Collections
Right arrow CV surgery: aortic and vascular disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1278.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Infrarenal Aortic Diameter Predicts All-Cause Mortality

Paul Norman; Max Le; Carole Pearce; Konrad Jamrozik

From the School of Surgery and Pathology (P.N.), The University of Western Australia, Fremantle Hospital, Fremantle, Western Australia; School of Population Health (M.L., C.P.), The University of Western Australia, Nedlands, Western Australia; and the Department of Primary Health Care and General Practice (K.J.), Imperial College London and Visiting Professor, School of Population Health, University of Western Australia.

Correspondence to Paul Norman, University Department of Surgery, Fremantle Hospital, PO Box 480, Fremantle, Western Australia 6959. E-mail pnorman{at}cyllene.uwa.edu.au

Objective— To assess the relationship between infrarenal aortic diameter and subsequent all-cause mortality in men aged 65 years or older.

Methods and Results— Aortic diameter was measured using ultrasound in 12 203 men aged 65 to 83 years as part of a trial of screening for abdominal aortic aneurysms. A range of cardiovascular risk factors was also documented. Mortality over the next 3 to 7 years was assessed using record linkage. Initial aortic diameter was categorized into 10 intervals, and the relationship between increasing diameter and subsequent mortality was explored using Cox proportional hazard models. Median diameter increased from 21.4 mm in the youngest men to 22.1 mm in the oldest men. The cumulative all-cause mortality increased in a graded fashion with increasing aortic diameter. Using the diameter interval 19 to 22 mm as the reference, the adjusted hazard ratio for all-cause mortality increased from 1.26 (95% CI: 1.09, 1.44; P=0.001) for aortic diameters of 23 to 26 mm to 2.38 (95% CI: 1.22, 4.61; P=0.011) for aortic diameters of 47 to 50 mm. Analysis of causes of death indicated that cardiovascular disease was an important contributor to this increase.

Conclusion— Infrarenal aortic diameter is an independent marker of subsequent all-cause mortality.

Infrarenal aortic diameter was measured in 12 203 men. Cumulative mortality increased in a graded fashion with increasing aortic diameter. Using the interval 19 to 22 mm as the reference, the hazard ratio for all-cause mortality increased from 1.26 for aortic diameters of 23 to 26 mm to 2.38 for aortic diameters of 47 to 50 mm.


Key Words: aortic diameter • ultrasound • mortality




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
S. H. Forsdahl, S. Solberg, K. Singh, and B. K Jacobsen
Abdominal aortic aneurysms, or a relatively large diameter of non-aneurysmal aortas, increase total and cardiovascular mortality: the Tromso study
Int. J. Epidemiol., November 12, 2009; (2009) dyp320v2.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J.-a. Wang, X.-f. Chen, W.-f. Yu, H. Chen, X.-f. Lin, M.-j. Xiang, C.-f. Fang, Y.-x. Du, and B. Wang
Relationship of heavy drinking, lipoprotein (a) and lipid profile to infrarenal aortic diameter
Vascular Medicine, November 1, 2009; 14(4): 323 - 329.
[Abstract] [PDF]


Home page
CirculationHome page
N. Diehm and I. Baumgartner
Determinants of Aneurysmal Aortic Disease
Circulation, April 28, 2009; 119(16): 2134 - 2135.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
P. E Norman, L. Flicker, O. P Almeida, G. J Hankey, Z. Hyde, and K. Jamrozik
Cohort Profile: The Health In Men Study (HIMS)
Int. J. Epidemiol., February 1, 2009; 38(1): 48 - 52.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. Golledge, M. Karan, C. S. Moran, J. Muller, P. Clancy, A. E. Dear, and P. E. Norman
Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions
Eur. Heart J., March 1, 2008; 29(5): 665 - 672.
[Abstract] [Full Text] [PDF]